The shelf effectiveness introduces a standing dilution overhang. Monitor for a prospectus supplement or takedown notice, which would signal an actual offering and likely pressure the stock.
KMDA drugs
KMDA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $8.19entry
- T+1 · 2mo ago +5.86%α +4.73% · $8.67
- T+5 · 8w ago +7.08%α +4.52% · $8.77
- T+20 · 5w ago −6.11%α −9.28% · $7.69
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kamada Ltd's shelf registration statement on Form F-3 (File No. 333-298814) was declared effective by the SEC on September 15, 2026. This allows the company to offer and sell securities, including common shares, from time to time at its discretion, creating a potential dilution overhang for existing shareholders. The effectiveness itself is a procedural step and does not indicate an immediate offering, but the company now has the flexibility to access capital markets when needed.
Key Facts
- Kamada Ltd's shelf registration (Form F-3, File No. 333-298814) was declared effective by the SEC on September 15, 2026.
- The effectiveness allows the company to sell securities, including common shares, at its discretion over time.
- No specific offering size, pricing, or timing was disclosed in the filing.
Financial Impact
No immediate financial impact; the shelf registration provides optionality for future capital raises of an undisclosed amount.
Risk Factors
- Potential dilutive secondary offering at any time without further notice.
- Market may price in a discount due to the overhang, capping upside.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002976 |
| Document: 9999999995-26-002976-index.html | 9999999995-26-002976 |
| Document: 9999999995-26-002976.txt | 9999999995-26-002976 |
Track record
25 reports on KMDA
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.13% at T+20 after the Aug 12, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 6-K Bullish 6/10 No price data
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $7.71 to $8.11 Now $8.11 +5.19% ▲ +5.19% +6.88% vs SPY
- Nov 2, 202614d ago 6-K Neutral 2/10 Entry $7.36 to $7.71 Now $8.11 +10.19% ▲ +4.76% +4.68% vs SPY
- Oct 6, 20265w ago 6-K Neutral 4/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 6, 20265w ago Press Release Bullish 6/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 5, 20266w ago 6-K Neutral 2/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Sep 17, 20268w ago 6-K Bullish 6/10 Entry $8.67 to $8.83 Now $8.11 −6.46% ▲ +1.85% +1.24% vs SPY
- Sep 16, 20268w ago EFFECT Neutral 3/10 Viewing Entry $8.19 to $8.77 Now $8.11 −0.98% ▲ +7.08% +4.52% vs SPY
- Sep 10, 20269w ago 6-K Neutral 2/10 Entry $7.99 to $8.67 Now $8.11 +1.50% ▲ +8.51% +9.01% vs SPY
- Sep 3, 202610w ago Press Release Neutral 2/10 Entry $8.54 to $8.31 Now $8.11 −5.04% ▼ −2.69% −1.48% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers